AA
GLSI icon

Ancora Advisors’s Greenwich LifeSciences GLSI Stock Holding History

Ancora Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Sell
10,740
-26,760
-71% -$651K ﹤0.01% 686
2026
Q1 		$901K Buy
+37,500
New +$978K 0.02% 423

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ancora Advisors's GLSI Position: Q2 2026 in Review

Ancora Advisors reduced its Greenwich LifeSciences (GLSI) stake by 71% in Q2 2026, selling an estimated $651K and leaving 10,740 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Ancora Advisors first reported a position in GLSI in Q1 2026 and has held it in 2 quarters since. The position peaked at $901K in Q1 2026. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Ancora Advisors held 10,740 shares of Greenwich LifeSciences worth $252K as of Q2 2026.
  • Ancora Advisors sold 26,760 Greenwich LifeSciences shares in Q2 2026, an estimated $651K.
  • Greenwich LifeSciences made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #686 holding.
  • Ancora Advisors first reported a position in Greenwich LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • Ancora Advisors's Greenwich LifeSciences position peaked at $901K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.